Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Cancer Patients”

9,318 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 9,318 results

Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Not applicableStudy completedNCT02579551
What this trial is testing

Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery

Who this might be right for
Skin Basal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 179
Testing effectiveness (Phase 2)Study completedNCT03389295
What this trial is testing

Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Xiayun He, MD 118
Testing effectiveness (Phase 2)Study completedNCT02844439
What this trial is testing

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

Who this might be right for
GlioblastomaRecurrent GlioblastomaBrain Tumor
Kadmon Corporation, LLC 40
Testing effectiveness (Phase 2)Ended earlyNCT02465957
What this trial is testing

QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)

Who this might be right for
Stage IIIB Merkel Cell CarcinomaStage IV Merkel Cell Carcinoma
ImmunityBio, Inc. 7
Not applicableStudy completedNCT00025012
What this trial is testing

Isotretinoin in Preventing Skin Cancer

Who this might be right for
Melanoma (Skin)Non-melanomatous Skin Cancer
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Testing effectiveness (Phase 2)Study completedNCT00002619
What this trial is testing

Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors

Who this might be right for
Brain and Central Nervous System Tumors
NYU Langone Health 60
Early research (Phase 1)Ended earlyNCT00290719
What this trial is testing

Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
University of California, San Francisco 6
Early research (Phase 1)Study completedNCT00001565
What this trial is testing

Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy

Who this might be right for
Brain NeoplasmsNeuroblastoma
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT01093222
What this trial is testing

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

Who this might be right for
Extrahepatic Bile Duct AdenocarcinomaGallbladder AdenocarcinomaGallbladder Adenocarcinoma With Squamous Metaplasia+6 more
National Cancer Institute (NCI) 40
Post-approval studies (Phase 4)Study completedNCT03610022
What this trial is testing

Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1

Who this might be right for
Metastatic Basal Cell CarcinomaLocally Advanced Basal Cell Carcinoma
University Hospital, Bordeaux 27
Not applicableStudy completedNCT06550739
What this trial is testing

Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Haike Lei 1,053
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Testing effectiveness (Phase 2)Looking for participantsNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 245
Testing effectiveness (Phase 2)Study completedNCT04170556
What this trial is testing

Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)

Who this might be right for
Hepatocellular Carcinoma
Fundacion Clinic per a la Recerca Biomédica 69
Testing effectiveness (Phase 2)Study completedNCT03520231
What this trial is testing

Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases

Who this might be right for
Urothelial CarcinomaKidney CancerUreter Cancer+1 more
University Health Network, Toronto 6
Not applicableEnded earlyNCT00631137
What this trial is testing

Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma

Who this might be right for
Brain and Central Nervous System TumorsMusculoskeletal Complications
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Large-scale testing (Phase 3)Not Yet RecruitingNCT06980545
What this trial is testing

Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer

Who this might be right for
Stage III and IV Ovarian Cancer
Assiut University 50
Early research (Phase 1)Ended earlyNCT00428272
What this trial is testing

HGS-ETR2 to Treat Children With Solid Tumors

Who this might be right for
Ewing's SarcomaOsteosarcomaNeuroblastoma+1 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Active Not RecruitingNCT03655002
What this trial is testing

IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer

Who this might be right for
Recurrent Hepatocellular CarcinomaRefractory Liver CarcinomaStage IV Hepatocellular Carcinoma AJCC v8+2 more
City of Hope Medical Center 8
Load More Results